<!DOCTYPE html>
<html lang="en">
  <head>

    <title>RPC Rounds | Best Ophthalmology Blog for Residents & Fellows</title>
    <link rel='icon' href='favicon.ico' type='image/x-icon'/>
<!-- below is facebook og -->
<meta property="og:url"           content="https://www.sadbhaavclinic.com/gradings.html" />
<meta property="og:type"          content="article" />
<meta property="og:title"         content="RPC Rounds | Gradings & Stagings in Ophthalmology" />
<meta property="og:description"   content="Gradings & Stagings in Ophthalmology" />
<meta property="og:image"         content="https://www.sadbhaavclinic.com/images/gradings.jpeg" />
<!-- above is facebook og -->
    <meta charset="utf-8">
    <meta name="Robots" content="all">
    <meta name="Googlebot" content="index, follow">
    <meta name="Yahoobot" content="index, follow">
    <meta name="MSNbot" content="index, follow">
    <meta name="robots" content="Index, Follow">
    <meta name="allow-search" content="yes">
    <meta name="rating" content="General">
    <meta name="document-distribution" content="Global">
    <meta name="language" content="EN">
    <meta name="author" content="Sadbhaav Eye & Dental Clinic">
    <meta name="copyright" content="https://www.sadbhaavclinic.com">
    <meta name="reply-to" content="sadbhaavclinic@gmail.com">
    <meta name="geo.country" content="INDIA">
    <meta name="document-type" content="Public">
    <meta name="document-rating" content="Safe for Kids">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="description" content="This is very useful ophthalmology blog for residents and Fellows">
    <meta name="keywords" itemprop="keywords" content="RPC rounds, Ophthalmology, Blog, Ophthalmology blog,Eye manuals, Eye Books ">


    
    <link href="https://fonts.googleapis.com/css?family=Roboto:300,400,500,700&display=swap" rel="stylesheet">

    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">

    <link rel="stylesheet" href="css/animate.css">
    <link rel="stylesheet" href="css/owl.carousel.min.css">
    <link rel="stylesheet" href="css/owl.theme.default.min.css">
    <link rel="stylesheet" href="css/magnific-popup.css">
    
    
    <link rel="stylesheet" href="css/style.css">


<!-- JSON-LD markup generated by Google Structured Data Markup Helper. -->
<script type="application/ld+json">
{
  "@context" : "https://schema.org",
  "@type" : "LocalBusiness",
  "name" : "Sadbhaav Eye & Dental Clinic",
  "telephone" : "+91 701-691-2180",
  "email" : "sadbhaavclinic@gmail.com",
  "address" : {
    "@type" : "PostalAddress",
    "streetAddress" : "7, Second Floor, Palladium Business Hub, Opposite PVR Cinema, Above Pantaloons, Visat-Gandhinagar Highway,",
    "addressLocality" : "Motera, Ahmedabad",
    "addressCountry" : "India",
    "postalCode" : "380005"
  },
  "openingHoursSpecification" : {
    "@type" : "OpeningHoursSpecification",
    "dayOfWeek" : {
      "@type" : "DayOfWeek",
      "name" : "Monday to Saturday"
    },
    "opens" : "Please insert valid ISO 8601 date/time here. Examples: 2015-07-27 or 2015-07-27T15:30",
    "closes" : "Please insert valid ISO 8601 date/time here. Examples: 2015-07-27 or 2015-07-27T15:30"
  },
  "url" : "https://www.sadbhaavclinic.com/",
  "aggregateRating" : {
    "@type" : "AggregateRating",
    "ratingValue" : "5",
    "bestRating" : "5",
    "ratingCount" : "200"
  },
  "review" : {
    "@type" : "Review",
    "author" : {
      "@type" : "Person",
      "name" : "Google"
    }
  }
}
</script>
<script src="https://kit.fontawesome.com/8d5cac4b15.js" crossorigin="anonymous"></script> <!-- Fontawesome signed in kit -->
    <!-- Global site tag (gtag.js) - Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=UA-101953921-1"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'UA-101953921-1');
</script>
<!-- Google Ads Tag -->
<script data-ad-client="ca-pub-4676392635813919" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>

<script type='text/javascript' src='https://platform-api.sharethis.com/js/sharethis.js#property=5f366fc4be0c1d00127720a2&product=sop' async='async'></script>

  </head>
  <body>

    <div class="wrap">
      <div class="container">
        <div class="row">
          <div class="col-md-9 d-flex align-items-center">
            <p class="mb-0 phone pl-md-2">
              <a href="tel:+917016912180" class="mr-2" title="Call to Sadbhaav Clinic Mobile Number 701-691-2180"><span class="fa fa-phone mr-1"></span> +91 701-691-2180</a> 
              <a href="mailto:sadbhaavclinic@gmail.com" title="Email to sadbhaavclinic@gmail.com"><span class="fa fa-paper-plane mr-1"></span> sadbhaavclinic@gmail.com</a>
              <a href="#" title="Clinic Times are Morning 10:00am to 1:30pm, Evening 4:30pm to 8:30pm (Sunday Closed)"><span class="fa fa-clock-o mr-1"></span> Time: Morning 10:00am to 1:30pm, Evening 4:30pm to 8:30pm (Sunday Closed)</a></p>
          </div>
          <div class="col-md-3 d-flex justify-content-md-end">
            <div class="social-media">
              <p class="mb-0 d-flex">
                <a href="https://www.facebook.com/SadbhaavClinic/" title="SadbhaavClinic Facebook Page" class="d-flex align-items-center justify-content-center"><span class="fa fa-facebook"><i class="sr-only">Facebook</i></span></a>
                <a href="https://twitter.com/sadbhaavclinic" title="SadbhaavClinic on Twitter"class="d-flex align-items-center justify-content-center"><span class="fa fa-twitter"><i class="sr-only">Twitter</i></span></a>
                <a href="https://www.instagram.com/sadbhaavclinic/" title="SadbhaavClinic on Instagram" class="d-flex align-items-center justify-content-center"><span class="fa fa-instagram"><i class="sr-only">Instagram</i></span></a>
                <a href="https://www.linkedin.com/company/sadbhaavclinic/" title="SadbhaavClinic LinkedIn Page" class="d-flex align-items-center justify-content-center"><span class="fa fa-linkedin"><i class="sr-only">LinkedIn</i></span></a>
                <a href="https://in.pinterest.com/sadbhaavclinic/" title="SadbhaavClinic on Pinterest" class="d-flex align-items-center justify-content-center"><span class="fa fa-pinterest"><i class="sr-only">Pinterest</i></span></a>
                <a href="https://api.whatsapp.com/send?phone=917016912180&text=I+need+to+book+an+appointment" title="Message SadbhaavClinic on Whatsapp" class="d-flex align-items-center justify-content-center"><span class="fa fa-whatsapp"><i class="sr-only">whatsapp</i></span></a>
                <a href="https://www.youtube.com/channel/UCn8Oxy6CKxwi9PKAVVgWwcg?view_as=subscriber"class="d-flex align-items-center justify-content-center" title="SadbhaavClinic Youtube channel"><span class="fa fa-youtube"><i class="sr-only">youtube</i></span></a>
              </p>
            </div>
          </div>
        </div>
      </div>
    </div>
    
    <nav class="navbar navbar-expand-lg navbar-dark ftco_navbar bg-dark ftco-navbar-light" id="ftco-navbar">
      <div class="container">
        <a class="navbar-brand" href="ophthalmology.html" title="One of the Best Rated Eye & Dental Clinic in Ahmedabad by AIIMS New Delhi Alumnus">RPC Rounds | Ophthalmology Blog</a>
        <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#ftco-nav" aria-controls="ftco-nav" aria-expanded="false" aria-label="Toggle navigation">
          <span class="oi oi-menu"></span> Menu
        </button>
        <div class="collapse navbar-collapse" id="ftco-nav">
          <ul class="navbar-nav ml-auto">
            <li class="nav-item"><a href="index.html" title="Home Page" class="nav-link">Home</a></li>
            <li class="nav-item"><a href="aboutus.html" title="About us" class="nav-link">About</a></li>
            <li class="nav-item"><a href="eyedepartment.html" title="Eye Department" class="nav-link">Eye</a></li>
            <li class="nav-item"><a href="dentaldepartment.html" title="Dental Department" class="nav-link">Dental</a></li>
            <li class="nav-item"><a href="cases.html" title="Clinical Cases" class="nav-link">Cases</a></li>
            <li class="nav-item"><a href="patientzone.html" title="Patients' Zone" class="nav-link">Patients' Zone</a></li>
            <li class="nav-item active"><a href="ophthalmology.html" title="Patients' Zone" class="nav-link">Ophthalmology Blog</a></li>
            <li class="nav-item"><a href="testimonials.html" title="Testimonials" class="nav-link">Testimonials</a></li>
            <li class="nav-item"><a href="contactus.html" title="Contact us" class="nav-link">Contact</a></li>
          </ul>
        </div>
      </div>
    </nav>
    <!-- END nav -->
    
<br>

    <section class="ftco-section ftco-degree-bg">
      <div class="container">
        <div class="row">
          <div class="col-lg-9 ftco-animate">
          	<p>
              <img src="images/gradings.jpeg" alt="" class="img-fluid">
            </p>
            <h1 class="mb-3" style= "color: orange";>Gradings & Stagings in Ophthalmology</h1>
            <div class="text pl-8">

<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319667"><span style="mso-bidi-language: AR-SA;">ADA Evidence
Grading System for Clinical Practice Recommendations</span></a><span style="mso-bidi-language: AR-SA;"></span></h3>
<div class="MsoNormal">
<br /></div>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-border-insideh: .5pt solid windowtext; mso-border-insidev: .5pt solid windowtext; mso-yfti-tbllook: 1184;">
 <thead>
<tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
   <td style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; padding: 0.75pt;" valign="bottom"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<b style="mso-bidi-font-weight: normal;"><span style="color: #c00000; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Level of evidence</span></b></div>
</td>
   <td style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; padding: 0.75pt;" valign="bottom"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<b style="mso-bidi-font-weight: normal;"><span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Description</span></b></div>
</td>
  </tr>
</thead>
 <tbody>
<tr style="mso-yfti-irow: 1;">
  <td rowspan="3" style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<b style="mso-bidi-font-weight: normal;"><span style="color: #c00000; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">A</span></b></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Clear evidence from <b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;">well-conducted,
  generalizable, randomized controlled trials</i></b> that are adequately
  powered, including: </span></div>
<div class="MsoNormal" style="line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; mso-list: l17 level1 lfo17; tab-stops: list .5in; text-indent: -0.25in;">
<span style="color: #006600; font-family: Symbol; font-size: 10pt; mso-bidi-font-family: Symbol; mso-bidi-language: AR-SA; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Evidence from a well-conducted multicenter trial</span></div>
<div class="MsoNormal" style="line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; mso-list: l17 level1 lfo17; tab-stops: list .5in; text-indent: -0.25in;">
<span style="color: #006600; font-family: Symbol; font-size: 10pt; mso-bidi-font-family: Symbol; mso-bidi-language: AR-SA; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Evidence from a meta-analysis that incorporated
  quality ratings in the analysis</span></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 2;">
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Compelling nonexperimental evidence,
  i.e., the “all or none” rule developed by the Centre for Evidence-Based
  Medicine at Oxford</span></div>
</td>
  <td style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<br /></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 3;">
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Supportive evidence from
  well-conducted randomized controlled trials that are adequately powered,
  including: </span></div>
<div class="MsoNormal" style="line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; mso-list: l23 level1 lfo18; tab-stops: list .5in; text-indent: -0.25in;">
<span style="color: #006600; font-family: Symbol; font-size: 10pt; mso-bidi-font-family: Symbol; mso-bidi-language: AR-SA; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Evidence from a well-conducted trial at one or more
  institutions</span></div>
<div class="MsoNormal" style="line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; mso-list: l23 level1 lfo18; tab-stops: list .5in; text-indent: -0.25in;">
<span style="color: #006600; font-family: Symbol; font-size: 10pt; mso-bidi-font-family: Symbol; mso-bidi-language: AR-SA; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Evidence from a meta-analysis that incorporated
  quality ratings in the analysis</span></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; mso-list: l23 level1 lfo18; tab-stops: list .5in; text-indent: -0.25in;">
<span style="color: black; font-family: Symbol; font-size: 10pt; mso-bidi-font-family: Symbol; mso-bidi-language: AR-SA; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span style="color: black; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">&nbsp;</span></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 4;">
  <td rowspan="2" style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<b style="mso-bidi-font-weight: normal;"><span style="color: #c00000; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">B</span></b></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Supportive evidence from <b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;">well-conducted
  cohort studies</i></b>, including: </span></div>
<div class="MsoNormal" style="line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; mso-list: l13 level1 lfo19; tab-stops: list .5in; text-indent: -0.25in;">
<span style="color: #006600; font-family: Symbol; font-size: 10pt; mso-bidi-font-family: Symbol; mso-bidi-language: AR-SA; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Evidence from a well-conducted prospective cohort
  study or registry</span></div>
<div class="MsoNormal" style="line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; mso-list: l13 level1 lfo19; tab-stops: list .5in; text-indent: -0.25in;">
<span style="color: #006600; font-family: Symbol; font-size: 10pt; mso-bidi-font-family: Symbol; mso-bidi-language: AR-SA; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Evidence from a well-conducted meta-analysis of
  cohort studies</span></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;"><br /></td>
 </tr>
<tr style="mso-yfti-irow: 5;">
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Supportive evidence from a <b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;">well-conducted
  case-control study</i></b></span></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<br /></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 6;">
  <td rowspan="2" style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<b style="mso-bidi-font-weight: normal;"><span style="color: #c00000; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">C</span></b></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Supportive evidence from <b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;">poorly
  controlled or uncontrolled studies</i></b>, including: </span></div>
<div class="MsoNormal" style="line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; mso-list: l3 level1 lfo20; tab-stops: list .5in; text-indent: -0.25in;">
<span style="color: #006600; font-family: Symbol; font-size: 10pt; mso-bidi-font-family: Symbol; mso-bidi-language: AR-SA; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Evidence from randomized clinical trials with one or
  more major or three or more minor methodological flaws that could invalidate
  the results </span></div>
<div class="MsoNormal" style="line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; mso-list: l3 level1 lfo20; tab-stops: list .5in; text-indent: -0.25in;">
<span style="color: #006600; font-family: Symbol; font-size: 10pt; mso-bidi-font-family: Symbol; mso-bidi-language: AR-SA; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Evidence from observational studies with high
  potential for bias (such as case series with comparison to historical
  controls)</span></div>
<div class="MsoNormal" style="line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; mso-list: l3 level1 lfo20; tab-stops: list .5in; text-indent: -0.25in;">
<span style="color: #006600; font-family: Symbol; font-size: 10pt; mso-bidi-font-family: Symbol; mso-bidi-language: AR-SA; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Evidence from case series or case reports</span></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;"><br /></td>
 </tr>
<tr style="mso-yfti-irow: 7;">
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Conflicting evidence with the weight
  of evidence supporting the recommendation</span></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<br /></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 8; mso-yfti-lastrow: yes;">
  <td style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<b style="mso-bidi-font-weight: normal;"><span style="color: #c00000; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">E</span></b></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;"><span style="color: #006600; font-size: 10pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Expert consensus or clinical
  experience</span></i></b></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;"><br /></td>
 </tr>
</tbody></table>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319668">Grading of hypertensive retinopathy</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a;">Keith and Wegner (1939)</span></b> have
classified hypertensive retinopathy changes into following four grades:</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<span lang="EN" style="mso-ansi-language: EN;">Patients were grouped according to their ophthalmoscopic findings. As such,
this was the first system to correlate retinal findings with the hypertensive
disease state.</span></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<b style="mso-bidi-font-weight: normal;">Grade I:</b> It consists of mild generalized arteriolar attenuation, particularly
of small branches, with broadening of the arteriolar light reflex and vein
concealment.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<b style="mso-bidi-font-weight: normal;">Grade II:</b> It comprises marked generalized narrowing and focal
attenuation of arterioles associated with deflection of veins at arteriovenous
crossings (Salus’ sign).</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<b style="mso-bidi-font-weight: normal;">Grade III:</b> This consists of Grade II changes plus copper-wiring of
arterioles, banking of veins distal to arteriovenous crossings (Bonnet sign),
tapering of veins on either side of the crossings (Gunn sign) and right-angle
deflection of veins (Salu’s sign). Flame-shaped haemorrhages, cotton-wool spots
and hard exudates are also present.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<b style="mso-bidi-font-weight: normal;">Grade IV:</b> This consists of all changes of Grade III plus
silver-wiring of arterioles and papilloedema.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
(copper is cheaper than silver..
So copper comes first)</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<span style="font-size: 10pt; line-height: 115%;">One of the major limitations of this classification system is
the difficulty in distinguishing early hypertensive retinopathy grades (e.g.,
grade 1 from grade 2); thus, a modified classification has been recently
proposed.</span></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<b style="mso-bidi-font-weight: normal;"><span lang="EN" style="color: #e36c0a; mso-ansi-language: EN;">Scheie
classification (1953)</span></b></div>
<span face="" lang="EN" style="mso-ansi-language: EN;">Staging under this system is as follows: </span><br />
<ul type="disc">
<li class="MsoNormal" style="line-height: normal; mso-list: l21 level1 lfo13; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span lang="EN" style="mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Stage 0
     - Diagnosis of hypertension but no visible retinal abnormalities</span></li>
<li class="MsoNormal" style="line-height: normal; mso-list: l21 level1 lfo13; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span lang="EN" style="mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Stage 1
     - Diffuse arteriolar narrowing; no focal constriction</span></li>
<li class="MsoNormal" style="line-height: normal; mso-list: l21 level1 lfo13; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span lang="EN" style="mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Stage 2
     - More pronounced arteriolar narrowing with focal constriction</span></li>
<li class="MsoNormal" style="line-height: normal; mso-list: l21 level1 lfo13; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span lang="EN" style="mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Stage 3
     - Focal and diffuse narrowing, with retinal hemorrhage</span></li>
<li class="MsoNormal" style="line-height: normal; mso-list: l21 level1 lfo13; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span lang="EN" style="mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Stage 4
     - Retinal edema, hard exudates, optic disc edema</span></li>
</ul>
<span face="" lang="EN" style="mso-ansi-language: EN;">The Scheie classification also grades the light reflex changes from
arteriolosclerotic changes, as follows: </span><br />
<ul type="disc">
<li class="MsoNormal" style="line-height: normal; mso-list: l6 level1 lfo14; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span lang="EN" style="mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Grade 0
     - Normal</span></li>
<li class="MsoNormal" style="line-height: normal; mso-list: l6 level1 lfo14; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span lang="EN" style="mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Grade 1
     - Broadening of light reflex with minimal arteriolovenous compression</span></li>
<li class="MsoNormal" style="line-height: normal; mso-list: l6 level1 lfo14; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span lang="EN" style="mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Grade 2
     - Light reflex changes and crossing changes more prominent</span></li>
<li class="MsoNormal" style="line-height: normal; mso-list: l6 level1 lfo14; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span lang="EN" style="mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Grade 3
     - Copper-wire appearance; more prominent arteriolovenous compression</span></li>
<li class="MsoNormal" style="line-height: normal; mso-list: l6 level1 lfo14; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span lang="EN" style="mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Grade 4
     - Silver-wire appearance; severe arteriolovenous crossing changes</span></li>
<li class="MsoNormal" style="color: #990000; line-height: 12pt; mso-list: l6 level1 lfo14; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span face="" style="font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">Scheie Classification</span></li>
<li class="MsoNormal" style="color: black; line-height: 12pt; margin-bottom: 0in; mso-list: l6 level1 lfo14; tab-stops: list .5in;"><span face="" style="font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">&nbsp;</span></li>
</ul>
<table border="1" cellpadding="0" class="MsoNormalTable" style="mso-cellspacing: 1.5pt; mso-padding-alt: 1.5pt 1.5pt 1.5pt 1.5pt; mso-yfti-tbllook: 1184;">
 <thead>
<tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
   <td style="padding: 1.5pt;" valign="bottom"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<b><span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">Group</span></b><span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;"></span></div>
</td>
   <td style="padding: 1.5pt;" valign="bottom"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<b><span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">Hypertension</span></b><span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;"></span></div>
</td>
   <td style="padding: 1.5pt;" valign="bottom"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<b><span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">Arteriolar
   sclerosis</span></b><span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;"></span></div>
</td>
  </tr>
</thead>
 <tbody>
<tr style="mso-yfti-irow: 1;">
  <td style="padding: 1.5pt;" valign="top"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">0</span></div>
</td>
  <td style="padding: 1.5pt;" valign="top"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">No
  changes</span></div>
</td>
  <td style="padding: 1.5pt;" valign="top"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">Normal</span></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 2;">
  <td style="padding: 1.5pt;" valign="top"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">1</span></div>
</td>
  <td style="padding: 1.5pt;" valign="top"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">Barely
  detectable arteriolar narrowing</span></div>
</td>
  <td style="padding: 1.5pt;" valign="top"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">Barely
  detectable light reflex changes</span></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 3;">
  <td style="padding: 1.5pt;" valign="top"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">2</span></div>
</td>
  <td style="padding: 1.5pt;" valign="top"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">Obvious
  arteriolar narrowing with focal irregularities</span></div>
</td>
  <td style="padding: 1.5pt;" valign="top"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">Obvious
  increased light reflex changes</span></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 4;">
  <td style="padding: 1.5pt;" valign="top"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">3</span></div>
</td>
  <td style="padding: 1.5pt;" valign="top"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">Grade
  2 plus retinal hemorrhages or exudates</span></div>
</td>
  <td style="padding: 1.5pt;" valign="top"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">Copper
  wire arterioles</span></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 5; mso-yfti-lastrow: yes;">
  <td style="padding: 1.5pt;" valign="top"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">4</span></div>
</td>
  <td style="padding: 1.5pt;" valign="top"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">Grade
  3 plus papilledema</span></div>
</td>
  <td style="padding: 1.5pt;" valign="top"><div class="MsoNormal" style="line-height: 12pt; margin-bottom: 0in;">
<span face="" style="color: black; font-size: 10pt; mso-bidi-font-family: &quot;Times New Roman&quot;; mso-bidi-language: AR-SA;">Silver
  wire arterioles</span></div>
</td>
 </tr>
</tbody></table>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319669"><span lang="EN" style="mso-ansi-language: EN;">Modified
Scheie classification</span></a><span lang="EN" style="mso-ansi-language: EN;"></span></h3>
<span face="" lang="EN" style="mso-ansi-language: EN;">Staging is as follows:</span><br />
<ul type="disc">
<li class="MsoNormal" style="line-height: normal; mso-list: l18 level1 lfo15; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span lang="EN" style="mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Grade 0
     - No changes</span></li>
<li class="MsoNormal" style="line-height: normal; mso-list: l18 level1 lfo15; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span lang="EN" style="mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Grade 1
     - Barely detectable arterial narrowing</span></li>
<li class="MsoNormal" style="line-height: normal; mso-list: l18 level1 lfo15; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span lang="EN" style="mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Grade 2
     - Obvious arterial narrowing with focal irregularities</span></li>
<li class="MsoNormal" style="line-height: normal; mso-list: l18 level1 lfo15; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span lang="EN" style="mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Grade 3
     - Grade 2 plus retinal hemorrhages and/or exudates</span></li>
<li class="MsoNormal" style="line-height: normal; mso-list: l18 level1 lfo15; mso-margin-bottom-alt: auto; mso-margin-top-alt: auto; tab-stops: list .5in;"><span lang="EN" style="mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Grade 4
     - Grade 3 plus disc swelling</span></li>
</ul>
<div class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 5pt;">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span lang="EN" style="color: #e36c0a; mso-ansi-language: EN; mso-bidi-font-family: Calibri;">Classification
of hypertensive retinopathy by Wong and Mitchell</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a; mso-bidi-font-family: Calibri;"></span></b></div>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-border-insideh: .5pt solid windowtext; mso-border-insidev: .5pt solid windowtext; mso-yfti-tbllook: 1184;">
 <tbody>
<tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
  <td style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;"><span face="" style="color: red;">Grades</span></i></b><b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;"><span style="color: red; font-size: 12pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;"></span></i></b></div>
</td>
  <td style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<br /></div>
</td>
  <td style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;"><span face="" style="color: red;">Description</span></i></b><b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;"><span style="color: red; font-size: 12pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;"></span></i></b></div>
</td>
  <td style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<br /></div>
</td>
  <td style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;"><span face="" style="color: red;">Systemic
  associations</span></i></b><b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;"><span style="color: red; font-size: 12pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;"></span></i></b></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 1;">
  <td style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<span style="color: red; font-size: 12pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">No retinopathy</span></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><br /></td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<span style="color: #0070c0; font-size: 12pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">No detectable retinal signs</span></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><br /></td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<span style="color: #c00000; font-size: 12pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">None</span></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 2;">
  <td style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<span style="color: red; font-size: 12pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Mild retinopathy (retinal arteriolar signs
  only)</span></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><br /></td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<span style="color: #0070c0; font-size: 12pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">One or more of the following
  arteriolar signs: • Generalised arteriolar narrowing • Focal arteriolar
  narrowing • Arteriovenous nicking • Arteriolar wall opacity (silver wiring) </span></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><br /></td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<span style="color: #c00000; font-size: 12pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Modest* association with risk of
  clinical stroke, subclinical stroke, coronary heart disease, and mortality.</span></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 3;">
  <td style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<span style="color: red; font-size: 12pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Moderate retinopathy </span></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><br /></td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<span style="color: #0070c0; font-size: 12pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">One or more of the following retinal
  signs: • Haemorrhage (blot, dot, or flame shaped) • Microaneurysm •
  Cottonwool spot • Hard exudates </span></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><br /></td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<span style="color: #c00000; font-size: 12pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Strong† association with risk of
  clinical stroke, subclinical stroke, cognitive decline, and cardiovascular
  mortality</span></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 4; mso-yfti-lastrow: yes;">
  <td style="border: 1pt solid; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<span style="color: red; font-size: 12pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Malignant retinopathy </span></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><br /></td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<span style="color: #0070c0; font-size: 12pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Moderate retinopathy plus optic disc
  swelling‡</span></div>
</td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><br /></td>
  <td style="border-bottom: 1pt solid; border-left: none; border-right: 1pt solid; border-top: none; mso-border-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt; padding: 0.75pt;" valign="top"><div class="MsoNormal" style="line-height: 16.8pt; margin-bottom: 0in;">
<span style="color: #c00000; font-size: 12pt; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Strong association with mortality</span></div>
</td>
 </tr>
</tbody></table>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319670">Grading of DR:</a></h3>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #00b0f0;">1. Mild NPDR:</span></b> At least one microaneurysm or
intraretinal hemorrhage.</div>
<div class="MsoNormal">
Hard/soft exudates may or may not be present.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #00b0f0;">2. Moderate NPDR:</span></b> Moderate
microaneurysms/intraretinal hemorrhage.</div>
<div class="MsoNormal">
Early mild IRMA.</div>
<div class="MsoNormal">
Hard/soft exudates may or may not present.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #00b0f0;">3. Severe NPDR.</span></b> Any one of the following
(4-2-1 Rule):</div>
<div class="MsoNormal">
Four quadrants of severe microaneurysms/ intraretinal
hemorrhages.</div>
<div class="MsoNormal">
Two quadrants of venous beading.</div>
<div class="MsoNormal">
One quadrant of IRMA changes.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #00b0f0;">4. Very severe NPDR</span></b>. Any two of the following
(4-2-1 Rule):</div>
<div class="MsoNormal">
Four quadrants of severe microaneurysms/ intraretinal
hemorrhages.</div>
<div class="MsoNormal">
Two quadrants of venous beading.</div>
<div class="MsoNormal">
One quadrant of IRMA changes.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #00b0f0;">Proliferative diabetic retinopathy (PDR)</span></b></div>
<ol start="1" style="margin-top: 0in;" type="1">
<li class="MsoNormal" style="mso-list: l12 level1 lfo11;">PDR without HRCs (Early
     PDR) and</li>
<li class="MsoNormal" style="mso-list: l12 level1 lfo11;">PDR with HRCs (Advanced
     PDR). High risk characteristics (HRC) of PDR are as follows (Fig. 11.14F):</li>
</ol>
<div class="MsoNormal" style="margin-left: 0.75in; mso-list: l19 level1 lfo12; text-indent: -0.25in;">
<span style="mso-bidi-font-family: Calibri; mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">1.<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>NVD 1/4 to 1/3 of disc area with or without
vitreous haemorrhage (VH) or pre-retinal haemorrhage (PRH)</div>
<div class="MsoNormal" style="margin-left: 0.75in; mso-list: l19 level1 lfo12; text-indent: -0.25in;">
<span style="mso-bidi-font-family: Calibri; mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">2.<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>NVD &lt; 1/4 disc area with VH or PRH</div>
<div class="MsoNormal" style="margin-left: 0.75in; mso-list: l19 level1 lfo12; text-indent: -0.25in;">
<span style="mso-bidi-font-family: Calibri; mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">3.<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>NVE &gt; 1/2 disc area with VH or PRH</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #00b0f0;">clinically significant macular edema (CSME)</span></b> if
one of the following three criteria are present on slit-lamp examination with
90D lens:</div>
<ol start="1" style="margin-top: 0in;" type="1">
<li class="MsoNormal" style="mso-list: l11 level1 lfo24;">Thickening of the retina
     at or within 500 micron of the centre of the fovea.</li>
<li class="MsoNormal" style="color: red; mso-list: l11 level1 lfo24;"><span color="">Hard exudate at or within 500 micron of the centre
     of fovea associated </span><b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;">with adjacent retinal thickening</i></b><span color=""> </span><b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;">and not residual hard exudates
     remaining after the disappearance of retinal thickening</i></b></li>
<li class="MsoNormal" style="mso-list: l11 level1 lfo24;">Development of a zone of
     retinal thickening one disc diameter or larger in size, at least a part of
     which is within one disc diameter of the foveal centre.</li>
</ol>
<div class="MsoNormal" style="margin-left: 0.5in;">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319671">DME</a></h3>
<div class="MsoNormal" style="margin-left: 0.25in;">
Based on OCT DME can be classified
into different pattern such as </div>
<div class="MsoNormal" style="margin-left: 0.75in; mso-list: l10 level1 lfo22; text-indent: -0.25in;">
<span style="mso-bidi-font-family: Calibri; mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">1.<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>cystoid macular edema, </div>
<div class="MsoNormal" style="margin-left: 0.75in; mso-list: l10 level1 lfo22; text-indent: -0.25in;">
<span style="mso-bidi-font-family: Calibri; mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">2.<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>spongy swelling of the retina, </div>
<div class="MsoNormal" style="margin-left: 0.75in; mso-list: l10 level1 lfo22; text-indent: -0.25in;">
<span style="mso-bidi-font-family: Calibri; mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">3.<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>hard exudates, </div>
<div class="MsoNormal" style="margin-left: 0.75in; mso-list: l10 level1 lfo22; text-indent: -0.25in;">
<span style="mso-bidi-font-family: Calibri; mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">4.<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>serous detachment, </div>
<div class="MsoNormal" style="margin-left: 0.75in; mso-list: l10 level1 lfo22; text-indent: -0.25in;">
<span style="mso-bidi-font-family: Calibri; mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">5.<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>macular traction, </div>
<div class="MsoNormal" style="margin-left: 0.75in; mso-list: l10 level1 lfo22; text-indent: -0.25in;">
<span style="mso-bidi-font-family: Calibri; mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">6.<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>taut posterior hyaloid membrane.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319672"><span class="section-title-3">Grading of trachoma</span></a><span class="section-title-3"></span></h3>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a;">McCallan's classification</span></b></div>
<div class="MsoNormal">
McCallan in 1908, divided the clinical course of the
trachoma into following four stages:</div>
<ul style="margin-top: 0in;" type="disc">
<li class="MsoNormal" style="mso-list: l1 level1 lfo10;">Stage I (Incipient
     trachoma or stage of infiltration). It is characterized by hyperaemia of
     palpebral conjunctiva and immature follicles.</li>
<li class="MsoNormal" style="mso-list: l1 level1 lfo10;">Stage II (Established
     trachoma or stage of florid infiltration). It is characterized by
     appearance of mature follicles, papillae and progressive corneal pannus.</li>
<li class="MsoNormal" style="mso-list: l1 level1 lfo10;">Stage III (Cicatrising
     trachoma or stage of scarring). It includes obvious scarring of palpebral
     conjunctiva.</li>
<li class="MsoNormal" style="mso-list: l1 level1 lfo10;">Stage IV (Healed trachoma
     or stage of sequelae). The disease is quite and cured but sequelae due to
     cicatrisation give rise to symptoms.</li>
</ul>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a;">WHO</span></b></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
TF = trachomatous inflammation
(follicular): five or more follicles (&gt;0.5&nbsp;mm) on the superior tarsus</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
TI = trachomatous inflammation
(intense):diffuse involvement of the tarsal conjunctiva, obscuring 50% or more
of the normal deep tarsal vessels; papillae are present</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
TS = trachomatous conjunctival
scarring: easily visible fibrous white tarsal bands</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
TT = trachomatous trichiasis: at
least one lash touching the globe</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
CO = corneal opacity sufficient to
blur details of at least part of the pupillary margin</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319673"><span class="section-title-3">WHO grading of
Xerophthalmia</span></a><span class="section-title-3"></span></h3>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
XN = night blindness</div>
<div class="MsoNormal">
X1 = conjunctival xerosis (X1A) with Bitot spot (X1B)</div>
<div class="MsoNormal">
X2 = corneal xerosis</div>
<div class="MsoNormal">
X3 = corneal ulceration, less than one-third (X3A); more
than one-third (X3B)</div>
<div class="MsoNormal">
XS = corneal scar</div>
<div class="MsoNormal">
XF = xerophthalmic fundus</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319674">Grading of nucleus hardness on slit-lamp
biomicroscopy</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade I: Soft, White or greenish
yellow</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade II: Soft-medium, Yellowish</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade III: Medium-hard, Amber</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade IV: Hard, Brownish</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade V: Ultrahard, Blackish
(rock-hard)</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319675"></a><a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="4-u1.0-B978-0-7020-4093-1..00021-5--s024"></a><a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="4-u1.0-B978-0-7020-4093-1..00021-5--st02"></a><span style="mso-bookmark: _Toc373319675;"><span class="section-title-3">Grading of severity of Chemical
Injury</span></span><span class="section-title-3"></span></h3>
<div class="MsoNormal">
Grading is performed on the basis of corneal clarity and
severity of limbal ischaemia (Roper-Hall system); the latter is assessed by
observing the patency of the deep and superficial vessels at the limbus (Fig.
21.29A).<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="4-u1.0-B978-0-7020-4093-1..00021-5--ulis"></a> </div>
<table border="0" cellpadding="0" class="MsoNormalTable" style="mso-cellspacing: 1.5pt; mso-yfti-tbllook: 1184;">
 <tbody>
<tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
  <td style="padding: 0.75pt; width: 1.5pt;" width="2"><br /></td>
  <td style="padding: 0.75pt; width: 4%;" valign="top" width="4%"><br /></td>
  <td style="padding: 0.75pt;"><div class="MsoNormal">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="4-u1.0-B978-0-7020-4093-1..00021-5--u083"></a>Grade
  1 is characterized by clear cornea (epithelial damage only) and no limbal
  ischaemia (excellent prognosis).</div>
</td>
 </tr>
<tr style="mso-yfti-irow: 1;">
  <td style="padding: 0.75pt; width: 1.5pt;" width="2"><br /></td>
  <td style="padding: 0.75pt; width: 4%;" valign="top" width="4%"><br /></td>
  <td style="padding: 0.75pt;"><div class="MsoNormal">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="4-u1.0-B978-0-7020-4093-1..00021-5--u084">Grade 2
  shows hazy cornea but with visible iris details (Fig. 21.29B) and less than
  one-third of the limbus being ischaemic (good prognosis).</a></div>
</td>
  
 </tr>
<tr style="mso-yfti-irow: 2;">
  <td style="padding: 0.75pt; width: 1.5pt;" width="2"><br /></td>
  <td style="padding: 0.75pt; width: 4%;" valign="top" width="4%"><br /></td>
  <td style="padding: 0.75pt;"><div class="MsoNormal">
<span style="mso-bookmark: &quot;4-u1\.0-B978-0-7020-4093-1\.\.00021-5--u084&quot;;">Grade
  3 manifests total loss of corneal epithelium, stromal haze obscuring iris
  details (Fig. 21.29C) and between one-third and half limbal ischaemia
  (guarded prognosis).</span></div>
</td>
  
 </tr>
<tr style="mso-yfti-irow: 3; mso-yfti-lastrow: yes;">
  <td style="padding: 0.75pt; width: 1.5pt;" width="2"><br /></td>
  <td style="padding: 0.75pt; width: 4%;" valign="top" width="4%"><br /></td>
  <td style="padding: 0.75pt;"><div class="MsoNormal">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="4-u1.0-B978-0-7020-4093-1..00021-5--u085"></a>Grade
  4 shows opaque cornea (Fig. 21.29D) and more than half limbal ischaemia (very
  poor prognosis).</div>
</td>
 </tr>
</tbody></table>
<span style="mso-bookmark: &quot;4-u1\.0-B978-0-7020-4093-1\.\.00021-5--u084&quot;;"></span><span style="mso-bookmark: &quot;4-u1\.0-B978-0-7020-4093-1\.\.00021-5--u084&quot;;"></span>

<br />
<div class="MsoNormal" style="margin-left: 0.25in;">
<br /></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319676">PVR Gradings: (Retina Society Terminology
Committee, 1983)</a></h3>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">Grade A:</b> vitreous
changes (RPE clumps, protein flare)</div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">Grade B: </b>surface
wrinkling, rolled edge of tears, vascular tortuosity</div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">Grade C:</b> full
thickness retinal folds</div>
<div class="MsoNormal" style="text-indent: 0.5in;">
<b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;"><span style="color: #00b050;">Ryan:</span></i></b></div>
<div class="MsoNormal" style="text-indent: 0.5in;">
C1,C2,C3: 1,2,3 quadrent
respectively</div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;"><span style="color: #00b050;"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Jakobiec:</span></i></b></div>
<div class="MsoNormal" style="margin-left: 0.5in;">
C1: Posterior star fold</div>
<div class="MsoNormal" style="margin-left: 0.5in;">
C2: Posterior confluent irregular
folds</div>
<div class="MsoNormal" style="margin-left: 0.5in;">
C3: Posterior subretinal ‘napkin
irregular elevation of retina</div>
<div class="MsoNormal" style="margin-left: 0.5in;">
C4: Anterior irregular folds</div>
<div class="MsoNormal" style="margin-left: 0.5in;">
C5: Anterior smooth circumferential
retinal fold in coronal plane</div>
<div class="MsoNormal" style="margin-left: 0.5in;">
C6: Anterior circumferential fold
of retina at insertion of posterior hyaloid</div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">Grade D:</b> Fixed
Retinal Fold in four quadrents</div>
<div class="MsoNormal">
<span style="mso-tab-count: 1;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>D1:
Wide Funnel Shape</div>
<div class="MsoNormal">
<span style="mso-tab-count: 1;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>D2:
Narrow Funnel Shape</div>
<div class="MsoNormal">
<span style="mso-tab-count: 1;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>D3:
Closed Funnel Shape</div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;"><span style="color: #c00000;">This classification system has following
disadvantages:</span></i></b></div>
<div class="MsoNormal" style="margin-left: 0.25in; mso-list: l0 level1 lfo1; text-indent: -0.25in;">
<span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>There was no clinical correlation between the
most severe form (grade D) and visual prognosis.</div>
<div class="MsoNormal" style="margin-left: 0.25in; mso-list: l0 level1 lfo1; text-indent: -0.25in;">
<span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>There was limited quantification of extent of
disease.</div>
<div class="MsoNormal" style="margin-left: 0.25in; mso-list: l0 level1 lfo1; text-indent: -0.25in;">
<span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>This system did not include PVR anterior to the
equator.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #7030a0;">The new classification system consists of the following modified
PVR grades:</span></b></div>
<div class="MsoNormal">
A – Pigment clumps in the vitreous cavity, vitreous haze</div>
<div class="MsoNormal">
B – Retinal wrinkling breaks with rolled edges, retinal rigidity,
vascular tortuousity, and decreased vitreous mobility</div>
<div class="MsoNormal">
C – Full thickness fixed folds (subdivided into anterior and
posterior forms)</div>
<div class="MsoNormal">
Extent of involvement expressed in clock hours (subdivided into
contraction types):</div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">CP1-12</b></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">CA1-12</b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">1. Focal posterior</b>
– single or multiple isolated folds posterior to vitreous base.</div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">2. Diffuse posterior</b>
– confluence of focal epicenters posterior to vitreous base.</div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">3. Subretinal
proliferations</b> –bands of moth eaten sheets; extent quantified if retina is
elevated.</div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">4. Circumferential
traction</b> along the posterior edge of vitreous base with central displacement
of retina and radial folds posteriorly.</div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">5. Anterior traction</b>
– vitreous base displaced to pars plicata, iris or pupillary margin.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
Shortcomings of these classifications are that they <b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;"><span style="color: #c00000;">do not take into account important features that
influence the prognosis.</span></i></b></div>
<div class="MsoNormal">
1. Number, location and size of retinal breaks </div>
<div class="MsoNormal">
2. Number and type of previous operation</div>
<div class="MsoNormal">
3. Time course and biological activity of the proliferative process.</div>
<div class="MsoNormal">
<br /></div>
<h3 style="mso-list: l5 level1 lfo16;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319677"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Stages of development of PVR (</a><span style="mso-bookmark: _Toc373319677;"><span style="color: red;">CPEC</span>)</span></h3>
<ol start="1" style="margin-top: 0in;" type="1">
<li class="MsoNormal" style="mso-list: l22 level1 lfo9;">Cellular activation</li>
<li class="MsoNormal" style="mso-list: l22 level1 lfo9;">Proliferation</li>
<li class="MsoNormal" style="mso-list: l22 level1 lfo9;">Extracellular matrix
     elaboration and remodeling</li>
<li class="MsoNormal" style="mso-list: l22 level1 lfo9;">Contraction</li>
</ol>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319678">Eales’ Disease (</a><span style="mso-bookmark: _Toc373319678;"><span style="color: red;">PINK</span>)</span></h3>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #7030a0;">Charmis Classification:</span></b></div>
<ol start="1" style="margin-top: 0in;" type="1">
<li class="MsoNormal" style="mso-list: l24 level1 lfo8;">Stage of Active Phlebitis</li>
<li class="MsoNormal" style="mso-list: l24 level1 lfo8;">The Stage of Persistent
     Ischaemia</li>
<li class="MsoNormal" style="mso-list: l24 level1 lfo8;">The Stage of Vascular
     Proliferation</li>
<li class="MsoNormal" style="mso-list: l24 level1 lfo8;">The Stage of
     Complications</li>
</ol>
<div class="MsoNormal" style="tab-stops: 61.5pt;">
<b style="mso-bidi-font-weight: normal;"><span style="color: #7030a0;"><span style="mso-tab-count: 1;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></b></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #7030a0;">Eales’ disease staging system (Saxena S) </span></b></div>
<div class="MsoNormal">
This classification system is based on both fundoscopic and
fluorescein angiographic variables that have been shown to be prognostic of
visual outcome.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">A. Eales’ disease</b></div>
<div class="MsoNormal">
Stage 1a Periphlebitis of small caliber vessels with superficial
retinal hemorrhages</div>
<div class="MsoNormal">
Stage 1b Periphlebitis of large caliber vessels with superficial
retinal hemorrhages</div>
<div class="MsoNormal">
Stage 2a Peripheral capillary nonperfusion</div>
<div class="MsoNormal">
Stage 2b Neovascularization elsewhere /Neovascularisation of
the disc</div>
<div class="MsoNormal">
Stage 3a Fibrovascular proliferation</div>
<div class="MsoNormal">
Stage 3b Vitreous hemorrhage</div>
<div class="MsoNormal">
Stage 4a Traction / combined rhegmatogenous detachment</div>
<div class="MsoNormal">
Stage 4b Rubeosis iridis, neovascular glaucoma, complicated
cataract, and optic atrophy</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">B. Central Eales’
disease</b></div>
<div class="MsoNormal" style="text-indent: 0.25in;">
<br /></div>
<div class="MsoNormal" style="text-indent: 0.25in;">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319679">Macular Hole</a></h3>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
0: premacular hole </div>
<div class="MsoNormal">
1: impending macular holes</div>
<div class="MsoNormal">
small yellow spot (stage lA) or yellow ring (stage IB) in
the center of the fovea.</div>
<div class="MsoNormal">
2: A stage 2 macular hole represents the progression of a
foveal pseudocyst to a full thickness dehiscence, as a tractional break
develops in the “roof ” (inner layer) of the pseudocyst (&lt;400um)</div>
<div class="MsoNormal">
3: A stage 3 macular hole is a fully developed hole (&gt;400
um diameter),</div>
<div class="MsoNormal">
4: A stage 4 macular hole is a fully developed hole with a
complete posterior vitreous detachment signified by a Weiss ring</div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319680">Gass classification of ERM</a></h3>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
● Grade 0 – cellophane maculopathy</div>
<div class="MsoNormal">
So called due to cellophane-like sheen seen on
ophthalmoscopic examination</div>
<div class="MsoNormal">
No associated visual distortion</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
● Grade 1 – crinkled cellophane maculopathy</div>
<div class="MsoNormal">
Membrane causes an irregular wrinkling of inner retinal
surface (Figure 5)</div>
<div class="MsoNormal">
Contraction of the membrane causes formation of retinal
folds</div>
<div class="MsoNormal">
Fine superficial folds extend out from the margins of the
membrane</div>
<div class="MsoNormal">
If wrinkling is severe enough, paramacular vessels may be
pulled towards the fovea in a corkscrew</div>
<div class="MsoNormal">
formation. This is seen well on FFA</div>
<div class="MsoNormal">
Normally cystoid macular oedema, retinal haemorrhage,
exudates and retinal pigment epithelial</div>
<div class="MsoNormal">
disturbances are absent</div>
<div class="MsoNormal">
Patient will report visual disturbance and VAs of 6/12 or
worse are common</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
● Grade 2 – macular pucker</div>
<div class="MsoNormal">
Membrane will be thick and opaque, especially for those
membranes which develop following</div>
<div class="MsoNormal">
retinal detachment surgery</div>
<div class="MsoNormal">
Full thickness puckering of the macula may be present along
with oedema, small hemorrhages,</div>
<div class="MsoNormal">
cotton-wool spots and sometimes localised retinal detachment</div>
<div class="MsoNormal">
Vision will be severely debilitated with VAs often worse
than 6/60</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319681">Classiﬁcation of the posterior vitreoretinal
interface</a></h3>
<div class="MsoNormal">
0: No PVD</div>
<div class="MsoNormal">
1: Incomplete perifoveal PVD in up to 3 quadrants</div>
<div class="MsoNormal">
2: Incomplete perifoveal PVD in all 4 quadrants with
residual attachment to the fovea and optic disc</div>
<div class="MsoNormal">
3: Incomplete PVD over the posterior pole with residual
attachment to the optic disc</div>
<div class="MsoNormal">
4: Complete PVD identiﬁed biomicroscopically, but posterior
hyaloid face not visible on OCT imaging</div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319682"><span style="mso-bidi-language: AR-SA;">Stages of
Age-Related Posterior Vitreous Detachment</span></a><span style="mso-bidi-language: AR-SA;"></span></h3>
<div class="MsoNormal">
<span style="mso-bidi-language: AR-SA;">Stage 1: Perifoveal
separation with vitreofoveal adhesion.</span></div>
<div class="MsoNormal">
<span style="mso-bidi-language: AR-SA;">Stage 2: Complete
vitreomacular separation.</span></div>
<div class="MsoNormal">
<span style="mso-bidi-language: AR-SA;">Stage 3: Widespread
vitreous separation except at the optic disk margin.</span></div>
<div class="MsoNormal">
<span style="mso-bidi-language: AR-SA;">Stage 4: Complete,
clinically recognizable PVD.</span></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319683">Grading of angle width</a></h3>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a;">Shaffer system</span></b></div>
<div class="MsoNormal">
The Shaffer system records the angle in degrees between two
imaginary lines tangential to the inner surface of the trabeculum and the
anterior surface of the iris about one-third of the distance from its
periphery. In practice, the angle is graded by many according to the visibility
of various structures. The system assigns a numerical grade to each quadrant of
the angle as below (Fig. 10.17); it should be borne in mind that most angles
are narrowest superiorly.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal" style="margin-left: 0.25in; mso-list: l15 level1 lfo2; text-indent: -0.25in;">
<span style="font-family: Wingdings; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;"><span style="mso-list: Ignore;">ü<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;
</span></span></span>Grade 4 (35–45°) is the widest angle,
characteristic of myopia and aphakia, in which the ciliary body can be
visualized with ease.</div>
<div class="MsoNormal" style="margin-left: 0.25in; mso-list: l15 level1 lfo2; text-indent: -0.25in;">
<span style="font-family: Wingdings; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;"><span style="mso-list: Ignore;">ü<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;
</span></span></span>Grade 3 (25–35°) is an open angle in which at
least the scleral spur can be identified.</div>
<div class="MsoNormal" style="margin-left: 0.25in; mso-list: l15 level1 lfo2; text-indent: -0.25in;">
<span style="font-family: Wingdings; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;"><span style="mso-list: Ignore;">ü<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;
</span></span></span>Grade 2 (20°) is a moderately narrow angle in
which only the trabeculum can be identified.</div>
<div class="MsoNormal" style="margin-left: 0.25in; mso-list: l15 level1 lfo2; text-indent: -0.25in;">
<span style="font-family: Wingdings; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;"><span style="mso-list: Ignore;">ü<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;
</span></span></span>Grade 1 (10°) is a very narrow angle in which
only Schwalbe line, and perhaps also the top of the trabeculum, can be
identified.</div>
<div class="MsoNormal" style="margin-left: 0.25in; mso-list: l15 level1 lfo2; text-indent: -0.25in;">
<span style="font-family: Wingdings; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;"><span style="mso-list: Ignore;">ü<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;
</span></span></span>Slit angle is one in which there is no obvious
iridocorneal contact but no angle structures can be identified.</div>
<div class="MsoNormal" style="margin-left: 0.25in; mso-list: l15 level1 lfo2; text-indent: -0.25in;">
<span style="font-family: Wingdings; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;"><span style="mso-list: Ignore;">ü<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;
</span></span></span>Grade 0 (0°) is a closed angle due to
iridocorneal contact and is recognized by the inability to identify the apex of
the corneal wedge. Indentation gonioscopy will distinguish ‘appositional’ from
‘synechial’ angle closure (see Fig. 10.20).</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a;">R P C classification</span></b></div>
<div class="MsoNormal" style="margin-left: 0.25in;">
Grade 0<span style="mso-tab-count: 2;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Closed</div>
<div class="MsoNormal" style="margin-left: 0.25in;">
Grade 1<span style="mso-tab-count: 2;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>dipping of light</div>
<div class="MsoNormal" style="margin-left: 0.25in;">
Grade 2<span style="mso-tab-count: 2;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Schwalbe’s line visible</div>
<div class="MsoNormal" style="margin-left: 0.25in;">
Grade 3<span style="mso-tab-count: 2;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>anterior trabecular meshwork</div>
<div class="MsoNormal" style="margin-left: 0.25in;">
Grade 4<span style="mso-tab-count: 2;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>posterior T M scleral spur</div>
<div class="MsoNormal" style="margin-left: 0.25in;">
Grade 5<span style="mso-tab-count: 2;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>ciliary body band visible<span style="mso-tab-count: 1;"> </span></div>
<div class="MsoNormal" style="margin-left: 0.25in;">
Grade 6<span style="mso-tab-count: 2;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>root of iris visible</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #00b050; mso-bidi-language: AR-SA;">Grade the amount of TM pigment </span></b><b style="mso-bidi-font-weight: normal;"><span face="" style="color: #00b050; mso-bidi-font-family: Times-Roman; mso-bidi-language: AR-SA;">:</span></b></div>
<div class="MsoNormal">
<span face="" style="mso-bidi-font-family: Times-Roman; mso-bidi-language: AR-SA;">Scheie suggested a system of grading </span></div>
<div class="MsoNormal">
<span face="" style="mso-bidi-font-family: Times-Roman; mso-bidi-language: AR-SA;">0 none, +1 trace, +2 mild, +3 moderate, +4
severe</span></div>
<div class="MsoNormal">
<span face="" style="mso-bidi-font-family: Times-Roman; mso-bidi-language: AR-SA;">(+3 corresponds to iris pigmentation)</span></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319684">Grading anterior chamber cells (SUN-Standardization
of uveitis nomenclature)</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<span style="mso-spacerun: yes;">&nbsp;</span><b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;">Other grading systems are <span style="color: #548dd4;">Schlaegel’s &amp; Hogan’s.</span></i></b></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
&lt;1<span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>-0</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
1–5<span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp; </span>-±</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
6–15<span style="mso-spacerun: yes;">&nbsp; </span>-+1</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
16–25 -+2</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
26–50 -+3</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
&gt;50<span style="mso-spacerun: yes;">&nbsp;&nbsp; </span>-+4</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319685">Grading of aqueous flare (SUN Working Group Grading
Scheme)</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Nil<span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>-0</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Just detectable<span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>-+1</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Moderate (iris and lens details
clear)<span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>+2</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Marked (iris and lens details
hazy)<span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>+3</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Intense (fibrinous exudate)<span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>+4</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319686">Grading of vitreous haze</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h5>
According to EVS:</h5>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Good view of nerve fibre layer
(NFL)<span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Clear disc and vessels but hazy NFL<span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>+1</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Disc and vessels hazy<span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>+2</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Only disc visible<span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>+3</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Disc not visible<span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>+4</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319687">The grading of arteriolosclerosis:</a> </h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade 1: subtle broadening of the
arteriolar light reflex, mild generalized arteriolar attenuation, particularly
of small branches, and vein concealment.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade 2: obvious broadening of the
arteriolar light reflex and deflection of veins at arteriovenous crossings
(Salus sign).</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade 3:</div>
<div class="MsoNormal" style="margin-left: 1in; mso-list: l9 level1 lfo3; tab-stops: 80.15pt; text-indent: -0.25in;">
<span style="font-family: Wingdings; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;"><span style="mso-list: Ignore;">Ø<span style="font: 7pt &quot;times new roman&quot;;">&nbsp; </span></span></span>‘Copper-wiring’
of arterioles (Fig. 13.51C).</div>
<div class="MsoNormal" style="margin-left: 1in; mso-list: l9 level1 lfo3; tab-stops: 80.15pt; text-indent: -0.25in;">
<span style="font-family: Wingdings; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;"><span style="mso-list: Ignore;">Ø<span style="font: 7pt &quot;times new roman&quot;;">&nbsp; </span></span></span>Banking
of veins distal to arteriovenous crossings (Bonnet sign).</div>
<div class="MsoNormal" style="margin-left: 1in; mso-list: l9 level1 lfo3; tab-stops: 80.15pt; text-indent: -0.25in;">
<span style="font-family: Wingdings; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;"><span style="mso-list: Ignore;">Ø<span style="font: 7pt &quot;times new roman&quot;;">&nbsp; </span></span></span>Tapering
of veins on both sides of the crossings (Gunn sign) and right-angled deflection
of veins.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade 4: ‘Silver-wiring’ of
arterioles associated with grade 3 changes.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319688">Staging of ROP</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
The following five stages are used
to describe the abnormal vascular response at the junction of immature
avascular peripheral retina and vascularized posterior retina. Because more
than one ROP stage may be present in the same eye, staging for the eye as a
whole is determined by the most severe manifestation.</div>
<div class="MsoNormal" style="margin-left: 0.25in; mso-list: l0 level1 lfo1; tab-stops: 80.15pt; text-indent: -0.25in;">
<span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Stage 1 (demarcation line) is a thin, flat,
tortuous, grey-white line running roughly parallel with the ora serrata. It is
more prominent in the temporal periphery. There is abnormal branching or
‘arcading’ of vessels leading up to the line (Fig. 13.60A).</div>
<div class="MsoNormal" style="margin-left: 0.25in; mso-list: l0 level1 lfo1; tab-stops: 80.15pt; text-indent: -0.25in;">
<span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·</span></span></div>
<div class="MsoNormal" style="margin-left: 0.25in; mso-list: l20 level1 lfo4; tab-stops: 80.15pt; text-indent: -0.25in;">
<span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Stage 2 (ridge) arises in the region of the
demarcation line, has height and width, and extends above the plane of the
retina. Blood vessels enter the ridge and small isolated neovascular tufts
(‘popcorn’) may be seen posterior to it (Fig. 13.60B).</div>
<div class="MsoNormal" style="margin-left: 0.25in; mso-list: l20 level1 lfo4; tab-stops: 80.15pt; text-indent: -0.25in;">
<span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Stage 3 (extraretinal fibrovascular
proliferation) extends from the ridge into the vitreous (Fig. 13.60C). It is
continuous with the posterior aspect of the ridge, causing a ragged appearance
as the proliferation becomes more extensive. The severity of stage 3 can be
subdivided into mild, moderate and severe depending on the extent of
extraretinal fibrous tissue infiltrating the vitreous. The highest incidence of
this stage is around the post-conceptual age of 35 weeks.</div>
<div class="MsoNormal" style="margin-left: 0.25in; mso-list: l20 level1 lfo4; tab-stops: 80.15pt; text-indent: -0.25in;">
<span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Stage 4 (partial retinal detachment) is divided
into extrafoveal (stage 4A – Fig. 13.60D) and foveal (Stage 4B). The detachment
is generally concave and circumferentially orientated. In progressive cases the
fibrous tissue continues to contract and the detachment increases in height and
extends anteriorly and posteriorly.</div>
<div class="MsoNormal" style="margin-left: 0.25in; mso-list: l20 level1 lfo4; tab-stops: 80.15pt; text-indent: -0.25in;">
<span style="font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Stage 5 is a total retinal detachment.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3 style="mso-list: l20 level1 lfo4;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319689"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Grading of North Carolina macular dystrophy</a></h3>
<div class="MsoNormal" style="margin-left: 0.5in; mso-list: l8 level1 lfo5; tab-stops: 80.15pt; text-indent: -0.25in;">
<span style="mso-bidi-font-family: Calibri; mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">1.<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>Grade
1 is characterized by yellow-white, drusen-like peripheral (Fig. 15.33A) and
macular deposits which develop during the 1st decade and may remain
asymptomatic throughout life.</div>
<div class="MsoNormal" style="margin-left: 0.5in; mso-list: l8 level1 lfo5; tab-stops: 80.15pt; text-indent: -0.25in;">
<span style="mso-bidi-font-family: Calibri; mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">2.<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>Grade
2 is characterized by deep, confluent macular deposits (Fig. 15.33B). The
long-term visual prognosis is guarded because some patients develop neovascular
maculopathy (Fig. 15.33C) and subretinal scarring.</div>
<div class="MsoNormal" style="margin-left: 0.5in; mso-list: l8 level1 lfo5; tab-stops: 80.15pt; text-indent: -0.25in;">
<span style="mso-bidi-font-family: Calibri; mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">3.<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>Grade
3 is characterized by coloboma-like atrophic macular lesions (Fig. 15.33D)
associated with variable impairment of visual acuity.</div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319690"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Grading of binocular vision</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="margin-left: 0.5in; mso-list: l16 level1 lfo7; tab-stops: 80.15pt; text-indent: -0.25in;">
<span style="mso-bidi-font-family: Calibri; mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">1.<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>simultaneous
perception, SP</div>
<div class="MsoNormal" style="margin-left: 0.5in; mso-list: l16 level1 lfo7; tab-stops: 80.15pt; text-indent: -0.25in;">
<span style="mso-bidi-font-family: Calibri; mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">2.<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>fusion</div>
<div class="MsoNormal" style="margin-left: 0.5in; mso-list: l16 level1 lfo7; tab-stops: 80.15pt; text-indent: -0.25in;">
<span style="mso-bidi-font-family: Calibri; mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">3.<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>stereopsis</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319691"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>NVG</a> </h3>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
(a) rubeosis iridis, (b) secondary
open-angle glaucoma and (c) secondary synechial angle-closure glaucoma.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319692"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Stages of Proliferative retinopathy</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<b style="mso-bidi-font-weight: normal;">Stage 1</b> shows peripheral arteriolar occlusion and ischaemia.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<b style="mso-bidi-font-weight: normal;">Stage 2</b> is characterized by peripheral arteriovenous anastomoses of
dilated pre-existing capillary channels (Fig. 13.55A).</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<b style="mso-bidi-font-weight: normal;">Stage 3</b></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Sprouting of new vessels from the
anastomoses; these have a ‘sea-fan’ configuration and are usually fed by a
single arteriole and drained by a single vein (Fig. 13.55B and see Fig.
13.56A).</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
About 30–40% of sea-fans involute
spontaneously as a result of auto-infarction and appear as greyish
fibrovascular lesions (Fig. 13.55C). Involution most frequently occurs about 2
years after the development of retinopathy.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<b style="mso-bidi-font-weight: normal;">Stage 4.</b> The neovascular tufts may continue to proliferate and
bleed into the vitreous (Fig. 13.55D).</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<b style="mso-bidi-font-weight: normal;">Stage 5</b> is characterized by extensive fibrovascular proliferation
(Fig. 13.55E) and retinal detachment</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319693"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>ocular GVHD</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Jab et al. described four stages
of ocular GVHD: </div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Stage I – hyperemia; Stage II –
hyperemia with serosanguinous chemosis; Stage III – pseudomembranous
conjunctivitis; and Stage IV – pseudomembranous conjunctivitis with corneal
epithelial sloughing.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319694"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>OCP</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
The disease progression of OCP has
classically been documented into one of four stages.[7] Stage I denotes chronic
conjunctivitis with subepithelial fibrosis. Stage II refers to inferior fornix
foreshortening. Stage III describes symblepharon formation typically involving
the inferior fornix. Finally, stage IV is the end-stage characterized by
ankyloblepharon formation and corneal scarring</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319695"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>neurotrophic keratitis</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Mackie[45] characterized three
stages of neurotrophic keratitis. Stage one includes an often subtle irregular
corneal surface, which later develops into an easily recognized punctate
keratitis. Stage two is characterized by a frank epithelial defect, which
typically is associated with mild anterior stromal inflammation ( Fig. 4-17-9
). Folds in Descemet’s membrane often develop. The epithelium at the edges of
the defect tends to be characteristically “heaped up” with grayish, swollen
epithelium. The ulcer typically found in the lower, exposed, paracentral cornea
and is generally oval in shape ( Fig. 4-17-10 ). Stage three involves stromal
melting and occasionally perforation. Other characteristic symptoms include red
eye, mild foreign body sensation, blurred vision, and lid edema. The severity
of the anesthesia generally corresponds to the severity of the keratitis.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319696"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>spheroidal degeneration</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Three stages of the primary form
have been described:</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade I – fine shiny droplets are
present only peripherally without symptoms.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade II – the central cornea is
involved and vision may be as low as 20/100 (6/30).</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade III – there are large
corneal nodules and vision is no better than 20/200 (6/60).</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319697"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>PSR</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Because PSR can lead to severe
vision loss, it was classified into five stages by Goldberg. [2] [12] [15] This
progression of retinopathy typically occurs in the third or fourth decade of
life but has been noted as early as the second decade. The five stages are as
follows:</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
1.&nbsp;&nbsp;&nbsp;Peripheral
arteriolar occlusions.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
2.&nbsp;&nbsp;&nbsp;Arteriolar-venular
anastomoses.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
3.&nbsp;&nbsp;&nbsp;Neovascular
proliferation.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
4.&nbsp;&nbsp;&nbsp;Vitreous
hemorrhage.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
5.&nbsp;&nbsp;&nbsp;Retinal
detachment.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319698"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Lyme disease</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
is characterized by three main
stages:</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Primary, or initial, phase with
rash noted at the site of the inoculum (erythema chronicum migrans). Associated
flu-like symptoms can be noted.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Secondary or dissemination phase
with systemic signs and symptoms including dermatologic, neurologic, and
cardiac manifestations.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Tertiary or late phase with
associated arthritis, meningoencephalitis, polyneuropathies involving both
cranial and peripheral nerves, and carditis.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319699"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Sarcoidosis</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Stage I consists of bilateral
hilar adenopathy alone.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Stage II adds parenchymal
involvement.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
In stage III, parenchymal disease
predominates without prominent hilar involvement.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Stage IV is advanced disease
characterized by pulmonary fibrosis.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319700"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>RHABDOMYOSARCOMA</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
There are four stages:</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
I. Localized tumor, completely
resected</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
II. Regional spread, ± positive
nodes, grossly resected</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
III. Gross residual tumor
remaining after incomplete resection</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
IV. Distant metastases</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319701"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>OSD</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Van Bijsterveld created a grading
scale for rose bengal dye that divides the ocular surface into three zones:
nasal bulbar conjunctiva, cornea, and temporal bulbar conjunctiva, each graded
0–3 (0, none; 3, confluent staining).[36] Lemp and the National Eye
Institute/Industry Workshop group[15] suggest that the conjunctiva be divided
into six areas and graded in a similar manner ( Fig. 4-23-4 ). Alternatively,
lissamine green stains for cell death or degeneration, as well as cell-to-cell
junction disruption, but does not irritate the eye.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319702"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>RAPD</a></h3>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade I: weak initial constriction
followed by greater redilation; </div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade II: a slight “stall” in
movement, followed by a definite dilation; </div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade III: immediate pupillary
dilation [i.e., pupillary escape]; </div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade IV: pupillary dilation
during prolonged illumination of the contralateral eye for 6 seconds, followed
by constriction; </div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
Grade V: immediate pupillary
dilation and no signs of constriction), these systems are subject to
inter-observer errors and are affected by pupillary size; e.g., the small pupil
may not show a detectable initial constriction.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
The amount of pupillomotor input
asymmetry (the RAPD) may be estimated roughly using the alternating light test
(without any neutral density filters) and the subjective grades +1, +2, +3, or
+4 for asymmetry of pupillary response. </div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
This subjective grading also may
be categorized according to the amount of “pupil escape,” or dilatation of the
pupils, as the light is alternated between the eyes.[13] However, most
subjective grading of RAPDs has serious limitations, such as some large-scale
errors that arise from age variations in pupil size and pupil mobility. For
example, a patient who has small pupils and small pupillary contractions to
light may have a large RAPD, but this may appear deceptively small on the basis
of small differences in pupil excursion observed as the light is alternated
between the two eyes. However, the amount of neutral density filter needed to
dim the better eye until the small contractions are equal represents
substantial input damage. To estimate the size of RAPDs without using filters
is very much like the estimation of an ocular deviation “by Hirschberg” without
a prism cover test. More accurate quantification of RAPDs is accomplished by
determination of the log unit difference needed to “balance” the pupil reaction
between the two eyes. [4] [5] Photographic neutral density filters (49mm, screw
mount, 0.3 log, 0.6 log, and 0.9 log) often are available through local
photography stores.</div>
<div class="MsoNormal" style="tab-stops: 80.15pt;">
<br /></div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319703"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>VAN HERRICK GRADING OF THE PERIPHERAL ANTERIOR
CHAMBER DEPTH</a></h3>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
4: &gt; 1 PCT</div>
<div class="MsoNormal">
3: ¼ to ½ PCT</div>
<div class="MsoNormal">
2: ¼ PCT</div>
<div class="MsoNormal">
1: &lt; ¼ PCT</div>
<div class="MsoNormal">
Slit: Dangerously narrow</div>
<div class="MsoNormal">
<br /></div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319704"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>limbal chamber depth method</a></h3>
<div class="MsoNormal">
The limbal chamber depth method of grading the peripheral
anterior chamber is a recent modification of the van Herick test.[37] Instead
of the four grades used in the van Herick method, it has seven grades that are
expressed as a percentage fraction of the thickness of the adjacent cornea: 0%,
5%, 15%, 25%, 40%, 75%, and 100%. The limbal chamber depth method has been
demonstrated to perform better in the detection of established PACG and is now
widely used in epidemiologic research.</div>
<div class="MsoNormal">
<br /></div>
<h3 style="mso-list: l14 level1 lfo6;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319705"><span style="font-family: Symbol; font-weight: normal; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-fareast-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>GRADING OF HYPERDEVIATION</a></h3>
<div class="MsoNormal">
Trace: 5</div>
<div class="MsoNormal">
1+: 10</div>
<div class="MsoNormal">
2+: 20</div>
<div class="MsoNormal">
3+: 30</div>
<div class="MsoNormal">
4+: 45</div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319706">BEST’s Disease</a></h3>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
Best's disease has been described as going through four
phases based on fundus examination.</div>
<ol start="1" style="margin-top: 0in;" type="1">
<li class="MsoNormal" style="mso-list: l4 level1 lfo21;">The first, the <b style="mso-bidi-font-weight: normal;">previtelliform</b> stage, is
     characterized by a normal fundus appearance. </li>
<li class="MsoNormal" style="mso-list: l4 level1 lfo21;">The second stage, the <b style="mso-bidi-font-weight: normal;">vitelliform</b> stage, usually occurs
     in early childhood and is characterized by a well-circumscribed
     0.5-2-disk-diameter yellow lesion that looks like the yolk of an egg and
     appears to be located under the pigment epithelium. This is usually 0.5-2
     optic disk diameters in size. Acuity is usually normal or slightly
     reduced. The lesion may be unilateral, and a yellowish change may be noted
     in the RPE throughout the fundus. </li>
<li class="MsoNormal" style="mso-list: l4 level1 lfo21;">During the teenage years,
     or thereafter, the yellow lesion can break through the RPE into the
     subretinal space, and the yellow material can accumulate inferiorly in the
     macula in the subretinal space to form <b style="mso-bidi-font-weight: normal;">pseudohypopyon</b> (the third stage). </li>
<li class="MsoNormal" style="mso-list: l4 level1 lfo21;">A scrambled-egg
     appearance to the fundus then follows, with yellow deposits scattered <b style="mso-bidi-font-weight: normal;">throughout the posterior pole</b> (the
     fourth stage).</li>
</ol>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319707"><span style="mso-bidi-language: AR-SA;">Lasers</span></a></h3>
<div class="MsoNormal">
Lasers are divided into four “classes” based on their
strength of output.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a;">Class 1</span></b> lasers, with a maximum output that is <span style="mso-spacerun: yes;">&nbsp;</span><b style="mso-bidi-font-weight: normal;">&lt;0.4</b>
mW, are considered the <b style="mso-bidi-font-weight: normal;">safest</b> lasers
and are believed incapable of causing damage even if viewed for long periods of
time.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a;">Class 2</span></b> lasers have a maximum output <b style="mso-bidi-font-weight: normal;">&lt;1 mW</b>. These are also felt to be <b style="mso-bidi-font-weight: normal;">extremely unlikely</b> to result in ocular
injury because of protective mechanisms conferred by the body’s natural blink
response and aversion reflexes.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a;">Class 3A</span></b> lasers have a maximum output between <b style="mso-bidi-font-weight: normal;">1 mW and 5 mW</b>, and although they cannot
cause immediate eye injury, they can induce damage if stared directly at for <b style="mso-bidi-font-weight: normal;">sustained periods</b> of time. Most laser
pointers that are available in the United States are class 2 or class 3A
lasers.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a;">Class 3B</span></b> lasers are much more powerful, with a
maximum output between <b style="mso-bidi-font-weight: normal;">5 mW and 500 mW</b>.
These are believed to be capable of producing ocular damage <b style="mso-bidi-font-weight: normal;">immediately</b> upon viewing. Although
these lasers are illegal in some countries, they can be obtained quite easily
via the Internet. </div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a;">Class 4</span></b> lasers are the most powerful lasers,
boasting a maximal output <b style="mso-bidi-font-weight: normal;">&gt;500 mW</b>.
These are typically used in <b style="mso-bidi-font-weight: normal;">military and
occupational</b> settings, such as laser shows. They are capable of producing
extensive ocular damage. Given the brevity of our patient’s exposure that still
resulted in retinal injury, the laser involved was most likely a class 3B laser.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319708">VKH</a></h3>
<div class="MsoNormal">
<br /></div>
<ol start="1" style="margin-top: 0in;" type="1">
<li class="MsoNormal" style="mso-list: l7 level1 lfo23;"><b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a;">Prodromal phase</span></b> lasting a
     few days is characterized by neurological and auditory manifestations.</li>
</ol>
<div class="MsoNormal" style="margin-left: 0.5in;">
•&nbsp;&nbsp;&nbsp;Meningitis
causing headache and neck stiffness.</div>
<div class="MsoNormal" style="margin-left: 0.5in;">
•&nbsp;&nbsp;&nbsp;Encephalopathy
is less frequent and may manifest with convulsions, paresis and cranial nerve
palsies.</div>
<div class="MsoNormal" style="margin-left: 0.5in;">
•&nbsp;&nbsp;&nbsp;Auditory
features include tinnitus, vertigo and deafness.</div>
<div class="MsoNormal">
<br /></div>
<ol start="2" style="margin-top: 0in;" type="1">
<li class="MsoNormal" style="mso-list: l7 level1 lfo23;"><b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a;">Acute uveitic phase</span></b> follows
     soon thereafter and is characterized by bilateral granulomatous anterior
     or multifocal posterior uveitis and exudative retinal detachments.</li>
</ol>
<div class="MsoNormal" style="margin-left: 0.5in;">
<br /></div>
<ol start="3" style="margin-top: 0in;" type="1">
<li class="MsoNormal" style="mso-list: l7 level1 lfo23;"><b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a;">Convalescent phase</span></b> follows
     several weeks later and is characterized by:</li>
</ol>
<div class="MsoNormal" style="margin-left: 0.5in;">
•&nbsp;&nbsp;&nbsp;Localized
alopecia, poliosis and vitiligo (Fig. 11.69).</div>
<div class="MsoNormal" style="margin-left: 0.5in;">
•&nbsp;&nbsp;Focal depigmented
fundus lesions (<b style="mso-bidi-font-weight: normal;"><span style="color: red;">sunset
glow fundus</span></b>) and depigmented limbal lesions (<b style="mso-bidi-font-weight: normal;"><span style="color: red;">Sugiura sign</span></b>).</div>
<div class="MsoNormal" style="margin-left: 0.5in;">
<br /></div>
<ol start="4" style="margin-top: 0in;" type="1">
<li class="MsoNormal" style="mso-list: l7 level1 lfo23;"><b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a;">Chronic-recurrent phase</span></b> is
     characterized by smouldering anterior uveitis with exacerbations.</li>
</ol>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319709">Coat’s Disease:</a></h3>
<div class="MsoNormal">
stage 1, telangiectasia only;</div>
<div class="MsoNormal">
stage 2, telangiectasia and exudation (2A, extrafoveal; 2B
foveal); </div>
<div class="MsoNormal">
stage 3, exudative retinal detachment (3A, subtotal; 3B
total); </div>
<div class="MsoNormal">
stage 4, total detachment with secondary glaucoma; and </div>
<div class="MsoNormal">
stage 5, advanced end-stage disease.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319710"><span style="mso-bidi-language: AR-SA;">House-Brackmann
Facial Nerve Grading System</span></a><span style="mso-bidi-language: AR-SA;"></span></h3>
<div class="MsoNormal">
<span style="mso-bidi-language: AR-SA;">Grade Description
Characteristics</span></div>
<div class="MsoNormal">
<span face="" style="mso-bidi-font-family: Futura-Light; mso-bidi-language: AR-SA;">I Normal Normal
facial function</span></div>
<div class="MsoNormal">
<span face="" style="mso-bidi-font-family: Futura-Light; mso-bidi-language: AR-SA;">II Mild dysfunction
Very slight weakness found on close inspection; good forehead</span></div>
<div class="MsoNormal">
<span face="" style="mso-bidi-font-family: Futura-Light; mso-bidi-language: AR-SA;">function; complete
and quick eyelid closure</span></div>
<div class="MsoNormal">
<span face="" style="mso-bidi-font-family: Futura-Light; mso-bidi-language: AR-SA;">III Moderate
dysfunction Obvious but not disfiguring asymmetry; mild synkinesis; slight</span></div>
<div class="MsoNormal">
<span face="" style="mso-bidi-font-family: Futura-Light; mso-bidi-language: AR-SA;">forehead movement;
complete eyelid closure with effort</span></div>
<div class="MsoNormal">
<span face="" style="mso-bidi-font-family: Futura-Light; mso-bidi-language: AR-SA;">IV Moderately severe
dysfunction</span></div>
<div class="MsoNormal">
<span face="" style="mso-bidi-font-family: Futura-Light; mso-bidi-language: AR-SA;">Disfiguring asymmetry;
no forehead movement; incomplete</span></div>
<div class="MsoNormal">
<span face="" style="mso-bidi-font-family: Futura-Light; mso-bidi-language: AR-SA;">eyelid closure</span></div>
<div class="MsoNormal">
<span face="" style="mso-bidi-font-family: Futura-Light; mso-bidi-language: AR-SA;">V Severe dysfunction
Barely perceptible facial movement; incomplete eyelid closure</span></div>
<div class="MsoNormal">
<span face="" style="mso-bidi-font-family: Futura-Light; mso-bidi-language: AR-SA;">VI Total paralysis
No movement</span></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319711">FUCH’S DYSTROPHY</a></h3>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<span style="color: #231f20; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">The <b style="mso-bidi-font-weight: normal;">first stage</b> is asymptomatic, but guttae can be seen centrally on the
posterior aspect of a thickened Descemet membrane. In the <b style="mso-bidi-font-weight: normal;">second stage</b>, the patient may experience increased glare and a
painless decrease in vision due to corneal edema. The cornea may begin to
decompensate. In the <b style="mso-bidi-font-weight: normal;">third stage</b>,
vision deteriorates further owing to advanced corneal edema, and the patient
may experience pain from the formation of epithelial and subepithelial bullae.
The <b style="mso-bidi-font-weight: normal;">fourth stage</b> is characterized by
profound vision loss due to subepithelial scarring, which histologically
appears as diffuse avascular subepithelial connective tissue.</span></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319712"><span style="mso-bidi-language: AR-SA;">Corneal Ulcer</span></a><span style="mso-bidi-language: AR-SA;"></span></h3>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<span style="color: #231f20; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Stage 0: Stage of Infiltrate</span></div>
<div class="MsoNormal">
<span style="color: #231f20; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Stage 1: Progressive Stage</span></div>
<div class="MsoNormal">
<span style="color: #231f20; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Stage 2: Regressive Stage</span></div>
<div class="MsoNormal">
<span style="color: #231f20; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Stage 3: Healing Stage</span></div>
<div class="MsoNormal">
<br /></div>
<table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; mso-padding-alt: 0in 0in 0in 0in; mso-yfti-tbllook: 1536; width: 580px;">
 <tbody>
<tr style="height: 39.75pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
  <td style="border: 1pt solid rgb(255, 255, 204); height: 39.75pt; padding: 0.05in 0.1in; width: 115.15pt;" valign="top" width="154"><div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #231f20; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">CHARACTERISTIC </span></b></div>
</td>
  <td style="border-bottom: 1pt solid rgb(255, 255, 204); border-left: none; border-right: 1pt solid rgb(255, 255, 204); border-top: 2.25pt solid rgb(255, 255, 204); height: 39.75pt; mso-border-left-alt: solid #FFFFCC 1.0pt; padding: 0.05in 0.1in; width: 102.4pt;" valign="top" width="137"><div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp;
  </span>MILD </span></b></div>
</td>
  <td style="border-bottom: 1pt solid rgb(255, 255, 204); border-left: none; border-right: 1pt solid rgb(255, 255, 204); border-top: 2.25pt solid rgb(255, 255, 204); height: 39.75pt; mso-border-left-alt: solid #FFFFCC 1.0pt; padding: 0.05in 0.1in; width: 119.4pt;" valign="top" width="159"><div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #0070c0; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">MODERATE</span></b></div>
</td>
  <td style="border-bottom: 1pt solid rgb(255, 255, 204); border-left: none; border-right: 2.25pt solid rgb(255, 255, 204); border-top: 2.25pt solid rgb(255, 255, 204); height: 39.75pt; mso-border-left-alt: solid #FFFFCC 1.0pt; padding: 0.05in 0.1in; width: 98.1pt;" valign="top" width="131"><div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #00b050; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">SEVERE </span></b></div>
</td>
 </tr>
<tr style="height: 77.6pt; mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
  <td style="border-bottom: 2.25pt solid rgb(255, 255, 204); border-left: 1pt solid rgb(255, 255, 204); border-right: 1pt solid rgb(255, 255, 204); border-top: none; height: 77.6pt; mso-border-top-alt: solid #FFFFCC 1.0pt; padding: 0.05in 0.1in; width: 115.15pt;" valign="top" width="154"><div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #231f20; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">SIZE</span></b></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #231f20; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">DEPTH</span></b></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #231f20; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">INFILTRATE</span></b></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #231f20; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">SCLERA </span></b></div>
</td>
  <td style="border-bottom: 2.25pt solid rgb(255, 255, 204); border-left: none; border-right: 1pt solid rgb(255, 255, 204); border-top: none; height: 77.6pt; mso-border-left-alt: solid #FFFFCC 1.0pt; mso-border-top-alt: solid #FFFFCC 1.0pt; padding: 0.05in 0.1in; width: 102.4pt;" valign="top" width="137"><div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">&lt;2mm </span></b></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">&lt;20%</span></b></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">SUPERFICIAL<span style="mso-spacerun: yes;">&nbsp;&nbsp; </span></span></b></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #e36c0a; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">NOT INVOLVED </span></b></div>
</td>
  <td style="border-bottom: 2.25pt solid rgb(255, 255, 204); border-left: none; border-right: 1pt solid rgb(255, 255, 204); border-top: none; height: 77.6pt; mso-border-left-alt: solid #FFFFCC 1.0pt; mso-border-top-alt: solid #FFFFCC 1.0pt; padding: 0.05in 0.1in; width: 119.4pt;" valign="top" width="159"><div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #0070c0; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;"><span style="mso-spacerun: yes;">&nbsp;</span>2-5 mm</span></b></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #0070c0; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;"><span style="mso-spacerun: yes;">&nbsp;</span>20 –50 %</span></b></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #0070c0; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span>MID STROMAL</span></b></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #0070c0; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">NOT INVOLVED </span></b></div>
</td>
  <td style="border-bottom: 2.25pt solid rgb(255, 255, 204); border-left: none; border-right: 2.25pt solid rgb(255, 255, 204); border-top: none; height: 77.6pt; mso-border-left-alt: solid #FFFFCC 1.0pt; mso-border-top-alt: solid #FFFFCC 1.0pt; padding: 0.05in 0.1in; width: 98.1pt;" valign="top" width="131"><div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #00b050; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">&gt;5mm </span></b></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #00b050; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">&gt;50 %</span></b></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #00b050; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;"><span style="mso-spacerun: yes;">&nbsp;</span>DEEPER</span></b></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #00b050; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;"><span style="mso-spacerun: yes;">&nbsp;</span>MAY BE </span></b></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="color: #00b050; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">INVOLVED </span></b></div>
</td>
 </tr>
</tbody></table>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319713">PAPILLOEDEMA</a></h3>
<div class="MsoNormal">
<br /></div>
<table border="0" cellpadding="0" class="MsoNormalTable" style="mso-cellspacing: 1.5pt; mso-yfti-tbllook: 1184; width: 40%;">
 <tbody>
<tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
  <td style="padding: 0.75pt; width: 3.8%;" valign="top" width="3%"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<b><span style="mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">1</span></b><span style="mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;"> </span></div>
</td>
  <td style="padding: 0.75pt;"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="4-u1.0-B978-0-7020-4093-1..00019-7--o169"></a><b><span style="mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Early</span></b><span style="mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;"> </span></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 1;">
  <td style="padding: 0.75pt; width: 3.8%;" valign="top" width="3%"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<b><span style="mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">2
  </span></b></div>
</td>
  <td style="padding: 0.75pt;"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="4-u1.0-B978-0-7020-4093-1..00019-7--o171"></a><b><span style="mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Established </span></b></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 2;">
  <td style="padding: 0.75pt; width: 3.8%;" valign="top" width="3%"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<b><span style="mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">3
  </span></b></div>
</td>
  <td style="padding: 0.75pt;"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="4-u1.0-B978-0-7020-4093-1..00019-7--o176"></a><b><span style="mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Chronic </span></b></div>
</td>
 </tr>
<tr style="mso-yfti-irow: 3; mso-yfti-lastrow: yes;">
  <td style="padding: 0.75pt; width: 3.8%;" valign="top" width="3%"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<b><span style="mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">4
  </span></b></div>
</td>
  <td style="padding: 0.75pt;"><div class="MsoNormal" style="line-height: normal; margin-bottom: 0in;">
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="4-u1.0-B978-0-7020-4093-1..00019-7--o178"></a><b><span style="mso-bidi-font-family: Calibri; mso-bidi-language: AR-SA;">Atrophic </span></b></div>
</td>
 </tr>
</tbody></table>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319714">Stages of Filtering Bleb Infections</a></h3>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal" style="margin-left: 0.5in; mso-list: l2 level1 lfo25; tab-stops: list .5in; text-indent: -0.25in;">
<span style="font-family: Wingdings; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;"><span style="mso-list: Ignore;">l<span style="font: 7pt &quot;times new roman&quot;;">&nbsp; </span></span></span>Stage
1:<span style="mso-spacerun: yes;">&nbsp; </span></div>
<div class="MsoNormal" style="margin-left: 1in; mso-list: l2 level2 lfo25; tab-stops: list 1.0in; text-indent: -0.25in;">
<span style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;"><span style="mso-list: Ignore;">•<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Purulent bleb</div>
<div class="MsoNormal" style="margin-left: 1in; mso-list: l2 level2 lfo25; tab-stops: list 1.0in; text-indent: -0.25in;">
<span style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;"><span style="mso-list: Ignore;">•<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>+/- AC reaction</div>
<div class="MsoNormal" style="margin-left: 0.5in; mso-list: l2 level1 lfo25; tab-stops: list .5in; text-indent: -0.25in;">
<span style="font-family: Wingdings; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;"><span style="mso-list: Ignore;">l<span style="font: 7pt &quot;times new roman&quot;;">&nbsp; </span></span></span>Stage
2:<span style="mso-spacerun: yes;">&nbsp; </span></div>
<div class="MsoNormal" style="margin-left: 1in; mso-list: l2 level2 lfo25; tab-stops: list 1.0in; text-indent: -0.25in;">
<span style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;"><span style="mso-list: Ignore;">•<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Purulent bleb</div>
<div class="MsoNormal" style="margin-left: 1in; mso-list: l2 level2 lfo25; tab-stops: list 1.0in; text-indent: -0.25in;">
<span style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;"><span style="mso-list: Ignore;">•<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Moderate AC inflammation</div>
<div class="MsoNormal" style="margin-left: 0.5in; mso-list: l2 level1 lfo25; tab-stops: list .5in; text-indent: -0.25in;">
<span style="font-family: Wingdings; mso-bidi-font-family: Wingdings; mso-fareast-font-family: Wingdings;"><span style="mso-list: Ignore;">l<span style="font: 7pt &quot;times new roman&quot;;">&nbsp; </span></span></span>Stage
3:</div>
<div class="MsoNormal" style="margin-left: 1in; mso-list: l2 level2 lfo25; tab-stops: list 1.0in; text-indent: -0.25in;">
<span style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;"><span style="mso-list: Ignore;">•<span style="font: 7pt &quot;times new roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Endophthalmitis with marked AC reaction,
vitritis</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319715">Grading system of atrophia and phthisis bulbi</a></h3>
<div class="MsoNormal">
I Atrophy bulbi without shrinkage</div>
<div class="MsoNormal">
II Atrophia bulbi with shrinkage</div>
<div class="MsoNormal">
III Atrophia bulbi with shrinkage and disorganization
(phthisis bulbi)</div>
<div class="MsoNormal">
IV Phthisis bulbi with intraocular ossification</div>
<div class="MsoNormal">
V Phthisis bulbi with intraocular calcium deposition</div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319716">posterior staphyloma</a></h3>
<div class="MsoNormal" style="text-align: justify;">
<span face="" style="color: black; font-size: 9pt; line-height: 115%;">A posterior
staphyloma is a backward ectasia of the fundus, the hallmark being tessellation
and pallor of the area involved (Figure3). Posterior staphyloma can be of five
types[</span><span style="color: black;"><a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121"><span face="" style="font-size: 9pt; line-height: 115%;">7</span></a></span><span face="" style="color: black; font-size: 9pt; line-height: 115%;">]:-</span><span style="color: black; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; line-height: 115%; mso-bidi-font-family: Shruti;"></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span face="" style="color: black; font-size: 9pt; line-height: 115%;">Type 1- The area
of tessellation and pallor includes the region of the optic disc and macula. It
is the most common type</span><span style="color: black;"></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span face="" style="color: black; font-size: 9pt; line-height: 115%;">Type 2- includes
the region of the macula</span><span style="color: black;"></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span face="" style="color: black; font-size: 9pt; line-height: 115%;">Type 3- involves
the peri-papillary region</span><span style="color: black;"></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span face="" style="color: black; font-size: 9pt; line-height: 115%;">Type 4- extends
nasally from the disc</span><span style="color: black;"></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span face="" style="color: black; font-size: 9pt; line-height: 115%;">Type 5- most
rare and involves the fundus inferior to the optic disc</span><span style="color: black;"></span></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319717"><span style="mso-bidi-language: AR-SA;">Chorioretinal
Laser coagulation Grades</span></a><span style="mso-bidi-language: AR-SA;"></span></h3>
<div class="MsoNormal">
Grade 1/Light: Barely visible blanching of retinal pigment
epithelium (RPE)</div>
<div class="MsoNormal">
Grade 2/Mild: Hazy, faint white retinal coagulation</div>
<div class="MsoNormal">
Grade 3/Moderate: Opaque, dirty white retinal coagulation</div>
<div class="MsoNormal">
Grade 4/Heavy: Dense white, chalky retinal coagulation</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319718"><span style="mso-bidi-language: AR-SA;">Ectropion
Grading (Rubin et al)</span></a></h3>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
grade 1 — the lower punctum just pointing upwards away from
globe (punctal ectropion)</div>
<div class="MsoNormal">
grade 2 — partial everted lower lid and visible scleral show</div>
<div class="MsoNormal">
grade 3 — the presence of conjunctival hyperemia and gross
mucosal thickening and </div>
<div class="MsoNormal">
grade 4 — as for grade 3 with additional exposure keratitis</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
Depending upon the degree of outrolling, ectropion can be
divided into three grades. </div>
<div class="MsoNormal">
In grade I ectropion only punctum is everted.</div>
<div class="MsoNormal">
In grade II lid margin is everted and palpebral conjunctiva
is visible,</div>
<div class="MsoNormal">
In grade III the fornix is also visible.</div>
<div class="MsoNormal">
<br /></div>
<h3>
<a href="https://www.blogger.com/blogger.g?blogID=8285831235332798121" name="_Toc373319719">Cortical Visual Impairment</a></h3>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><i style="mso-bidi-font-style: normal;">Roman-Lantzy phases</i></b></div>
<div class="MsoNormal">
Phase is a period in the resolution of CVI that indicates
degree or severity of CVI.</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
Phase 1: building visual behavior</div>
<div class="MsoNormal">
Phase 2: integrating vision with function</div>
<div class="MsoNormal">
Phase 3: resolution of remaining CVI characteristics</div>




<p style="color: orange">- compiled & published by Dr Dhaval Patel MD AIIMS</p>
<!-- ShareThis BEGIN --><div class="sharethis-inline-share-buttons"></div><!-- ShareThis END -->
<br>
           </div>
 </div><!-- .col-md-8 -->


 <div class="col-lg-3 sidebar pl-lg-5 ftco-animate">
 
<h6 style="color: orange";>Among Top 30 Ophthalmology Blog</h6>
  <a href="https://blog.feedspot.com/ophthalmology_blogs/" title="Ophthalmology Blogs"><img alt=" Ophthalmology Blogs" src="https://blog.feedspot.com/wp-content/uploads/2018/03/ophthalmology_216px.png?x77178" /></a>

<h6 style="color: orange";>Amazon's Deals</h6>
<a href="https://www.amazon.in/gp/goldbox/ref=as_li_ss_tl?ie=UTF8&amp;linkCode=ll2&amp;tag=dhavalb20-21&amp;linkId=8408426555e21c5ab9ce5ea2d359de50" class="block-20 img d-flex align-items-center" style="background-image: url('images/amazondeal.png');"></a>

<div class="categories">
                <h6 style="color: orange";>Categories</h6>
                <li><a href="unitwise.html">RPC Unitwise Collection<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="cornea.html">Cornea<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="oculoplasty.html">Oculoplasty<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="glaucoma.html">Glaucoma<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="neurophthalmology.html">Neuro-ophthalmology<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="strabismus.html">Strabismus<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="lens.html">Lens<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="basicsciences.html">Basic Sciences<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="downloads.html">Downloads<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="exclusive.html">Exclusive<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="videos.html">Ophthalmology Videos<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="journals.html">Free Journals<span class="fa fa-chevron-right"></span></a></li>

               
</div>
</div>
</section>




      <footer class="ftco-footer">
      <div class="container">
        <div class="row mb-5">
          <div class="col-sm-12 col-md">
            <div class="ftco-footer-widget mb-4">
              <h2 class="ftco-heading-2 logo"><a href="sadbhaavclinic.com">Sadbhaav Clinic</a></h2>
              <p>Serving for Sight & Smile</p>
              <ul class="ftco-footer-social list-unstyled mt-2">
                <li class="ftco-animate"><a href="https://www.twitter.com/SadbhaavClinic/"><span class="fa fa-twitter"></span></a></li>
                <li class="ftco-animate"><a href="https://www.facebook.com/SadbhaavClinic/"><span class="fa fa-facebook"></span></a></li>
                <li class="ftco-animate"><a href="https://www.instagram.com/SadbhaavClinic/"><span class="fa fa-instagram"></span></a></li>
                <li class="ftco-animate"><a href="https://www.linkedin.com/company/SadbhaavClinic/"><span class="fa fa-linkedin"></span></a></li>
                <li class="ftco-animate"><a href="https://www.pinterest.com/SadbhaavClinic/"><span class="fa fa-pinterest"></span></a></li>
                <li class="ftco-animate"><a href="https://api.whatsapp.com/send?phone=917016912180&text=I+need+to+book+an+appointment"><span class="fa fa-whatsapp"></span></a></li>
                <li class="ftco-animate"><a href="https://www.youtube.com/channel/UCn8Oxy6CKxwi9PKAVVgWwcg?view_as=subscriber"><span class="fa fa-youtube"></span></a></li>
              </ul>
            </div>
          </div>
          <div class="col-sm-12 col-md">
            <div class="ftco-footer-widget mb-4 ml-md-4">
              <h2 class="ftco-heading-2">Medical Associations</h2>
              <ul class="list-unstyled">
                <li><a href="https://www.aao.org/"><span class="fa fa-chevron-right mr-2"></span>AAO</a></li>
                <li><a href="https://www.ascrs.org/"><span class="fa fa-chevron-right mr-2"></span>ASCRS</a></li>
                <li><a href="https://www.escrs.org/"><span class="fa fa-chevron-right mr-2"></span>ESCRS</a></li>
                <li><a href="https://www.aios.org/"><span class="fa fa-chevron-right mr-2"></span>AIOS</a></li>
                <li><a href="https://www.ahmedabadophthalmologicalsociety.org/"><span class="fa fa-chevron-right mr-2"></span>AOS</a></li>
                <li><a href="https://ahmedabadmedicalassociation.com/"><span class="fa fa-chevron-right mr-2"></span>AMA</a></li>
              </ul>
            </div>
          </div>
              <div class="col-sm-12 col-md">
             <div class="ftco-footer-widget mb-4">
              <h2 class="ftco-heading-2">Empanelment</h2>
              <ul class="list-unstyled">
                <li><a href="https://www.ongcindia.com/wps/wcm/connect/ongcindia/home/"><span class="fa fa-chevron-right mr-2"></span>ONGC</a></li>            
              </ul>
              <h2 class="ftco-heading-2">Ophthalmology Blog</h2>
              <ul class="list-unstyled">
                <li><a href="ophthalmology.html"><span class="fa fa-chevron-right mr-2"></span>RPC Rounds</a></li>           
              </ul>
            </div>
          </div>
          <div class="col-sm-12 col-md">
            <div class="ftco-footer-widget mb-4 ml-md-4">
              <h2 class="ftco-heading-2">Patients' Zone</h2>
              <ul class="list-unstyled">
                <li><a href="testimonials.html"><span class="fa fa-chevron-right mr-2"></span>Join us</a></li>
                <li ><a href="clinicupdates.html"><span class="fa fa-chevron-right mr-2"></span>Clinic Updates</a></li>
                <li ><a href="netragyan.html"><span class="fa fa-chevron-right mr-2"></span>નેત્ર-જ્ઞાન</a></li>
                <li ><a href="eyeinformation.html"><span class="fa fa-chevron-right mr-2"></span>Eye Information</a></li>
              </ul>
            </div>
          </div>

          <div class="col-sm-12 col-md">
            <div class="ftco-footer-widget mb-4">
              <h2 class="ftco-heading-2">Have a Questions?</h2>
              <div class="block-23 mb-3">
                <ul>

                  <li><span class="icon fa fa-map-marker"></span> <span class="text">7, Second Floor, Palladium Business Hub, Opposite PVR Cinema, Above Pantaloons, Visat-Gandhinagar Highway, Motera, Ahmedabad - 380005, India.</span></li>
                  <li><a href="tel:+917016912180"><span class="icon fa fa-phone"></span><span class="text">+91 701-691-2180</span></a></li>
                  <li><a href="mailto:sadbhaavclinic@gmail.com"><span class="icon fa fa-paper-plane pr-4"></span><span class="text">sadbhaavclinic@gmail.com</span></a></li>
                </ul>
              </div>
            </div>
          </div>
        </div>
      </div>
      
    </footer>
    
  

    
  

  <!-- loader -->
  <div id="ftco-loader" class="show fullscreen"><svg class="circular" width="48px" height="48px"><circle class="path-bg" cx="24" cy="24" r="22" fill="none" stroke-width="4" stroke="#eeeeee"/><circle class="path" cx="24" cy="24" r="22" fill="none" stroke-width="4" stroke-miterlimit="10" stroke="#F96D00"/></svg></div>


  <script src="js/jquery.min.js"></script>
  <script src="js/jquery-migrate-3.0.1.min.js"></script>
  <script src="js/popper.min.js"></script>
  <script src="js/bootstrap.min.js"></script>
  <script src="js/jquery.easing.1.3.js"></script>
  <script src="js/jquery.waypoints.min.js"></script>
  <script src="js/jquery.stellar.min.js"></script>
  <script src="js/owl.carousel.min.js"></script>
  <script src="js/jquery.magnific-popup.min.js"></script>
  <script src="js/jquery.animateNumber.min.js"></script>
  <script src="js/scrollax.min.js"></script>
  <script src="js/main.js"></script>
    
  </body>
</html>